Active Biotech AB (ACTI) — Strategic Asset Allocation Index
Active Biotech AB (ACTI) has a Strategic Asset Allocation Index of 3.6% as of December 2025. Strategic assets (PP&E of Skr2.00 Million plus long-term investments of Skr-) total Skr2.00 Million, measured against net assets of Skr55.60 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ACTI net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Active Biotech AB Strategic Asset Allocation Index (2000–2025)
This chart shows how Active Biotech AB's Strategic Asset Allocation Index has evolved across 26 annual periods from 2000 to 2025. As of December 2025, the index stands at 3.6%, representing strategic assets of Skr2.00 Million against net assets of Skr55.60 Million SEK. For live market cap and overall valuation, see Active Biotech AB market capitalisation.
Annual Strategic Asset Allocation Index for Active Biotech AB (2000–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Active Biotech AB from 2000 to 2025, covering 26 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ACTI total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 3.6% | Skr2.00 Million | Skr2.00 Million | Skr- | Skr55.60 Million | ▼ -6.9 pp |
| 2024 | 10.5% | Skr3.35 Million | Skr3.35 Million | Skr- | Skr32.07 Million | ▼ -4.9 pp |
| 2023 | 15.4% | Skr4.72 Million | Skr4.72 Million | Skr- | Skr30.67 Million | ▼ -2.9 pp |
| 2022 | 18.3% | Skr6.30 Million | Skr6.30 Million | Skr- | Skr34.51 Million | ▲ +16.2 pp |
| 2021 | 2.0% | Skr945.00K | Skr945.00K | Skr- | Skr46.67 Million | ▼ -6.4 pp |
| 2020 | 8.5% | Skr1.87 Million | Skr1.87 Million | Skr- | Skr22.11 Million | ▲ +2.5 pp |
| 2019 | 5.9% | Skr3.19 Million | Skr3.19 Million | Skr- | Skr53.78 Million | ▲ +4.5 pp |
| 2018 | 1.4% | Skr1.27 Million | Skr1.27 Million | Skr- | Skr87.92 Million | ▼ -0.8 pp |
| 2017 | 2.2% | Skr1.71 Million | Skr1.71 Million | Skr- | Skr77.68 Million | ▼ -177.5 pp |
| 2016 | 179.7% | Skr328.07 Million | Skr328.07 Million | Skr- | Skr182.56 Million | ▼ -2.9 pp |
| 2015 | 182.6% | Skr329.80 Million | Skr329.80 Million | Skr- | Skr180.60 Million | ▲ +88.5 pp |
| 2014 | 94.2% | Skr381.64 Million | Skr381.64 Million | Skr- | Skr405.31 Million | ▲ +0.2 pp |
| 2013 | 94.0% | Skr381.03 Million | Skr381.03 Million | Skr- | Skr405.41 Million | ▼ -18.2 pp |
| 2012 | 112.2% | Skr381.50 Million | Skr381.50 Million | Skr- | Skr339.92 Million | ▲ +36.0 pp |
| 2011 | 76.2% | Skr382.66 Million | Skr382.66 Million | Skr- | Skr501.99 Million | ▼ -121.0 pp |
| 2010 | 197.2% | Skr358.51 Million | Skr358.51 Million | Skr- | Skr181.76 Million | ▲ +28.1 pp |
| 2009 | 169.1% | Skr318.99 Million | Skr318.99 Million | Skr- | Skr188.64 Million | ▼ -29.3 pp |
| 2008 | 198.4% | Skr324.55 Million | Skr324.55 Million | Skr- | Skr163.61 Million | ▲ +24.4 pp |
| 2007 | 173.9% | Skr329.70 Million | Skr329.70 Million | Skr- | Skr189.57 Million | ▼ -402.1 pp |
| 2006 | 576.1% | Skr347.70 Million | Skr347.70 Million | Skr- | Skr60.36 Million | ▲ +362.9 pp |
| 2005 | 213.2% | Skr376.90 Million | Skr376.90 Million | Skr- | Skr176.81 Million | ▲ +189.1 pp |
| 2004 | 24.1% | Skr39.06 Million | Skr39.06 Million | Skr- | Skr162.30 Million | ▲ +6.7 pp |
| 2003 | 17.4% | Skr50.30 Million | Skr50.30 Million | Skr- | Skr289.58 Million | ▲ +1.5 pp |
| 2002 | 15.8% | Skr60.20 Million | Skr60.20 Million | Skr- | Skr380.27 Million | ▲ +4.9 pp |
| 2001 | 10.9% | Skr74.26 Million | Skr74.26 Million | Skr- | Skr678.78 Million | ▼ -19.6 pp |
| 2000 | 30.6% | Skr197.45 Million | Skr197.45 Million | Skr- | Skr646.03 Million | — |